Ivermectin
13 NDCs across 11 manufacturers|8 Generic,5 Brand
Ivermectin is used to treat ascariasis, elephantiasis, enterobiasis, mansonelliasis, onchocerciasis and scabies, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 22, 1996, and the first generic was approved Oct 24, 2014. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $13 million on Ivermectin across 81,000 claims for 51,000 beneficiaries.
Ivermectin is available as 13 NDCs from 11 manufacturers (8 generic, 5 brand), with NADAC prices from $0.29 to $15.51 per GM — the most expensive product costs about 54× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
8G / 5B
Manufacturers
11
competing in market
Price Spread
$0.29 – $15.51
per GM, 8 of 13 NDCs
7d Activity
avg -1.3% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
11 manufacturers producing IVERMECTIN(3 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SOOLANTRA 1% CREAM | $15.5133 per GM | -0.02% |
SOOLANTRA 1% CREAM | $11.6494 per GM | — |
STROMECTOL 3 MG TABLET | $4.4593 per EA | — |
STROMECTOL 3 MG TABLET | $4.4593 per EA | — |
IVERMECTIN 1% CREAM | $2.9675 per GM | -2.62% |
IVERMECTIN 1% CREAM | $2.9675 per GM | -2.62% |
IVERMECTIN 1% CREAM | $2.9675 per GM | -2.62% |
IVERMECTIN 1% CREAM | $2.9675 per GM | -2.62% |
IVERMECTIN 3 MG TABLET | $2.0633 per EA | +0.04% |
IVERMECTIN 3 MG TABLET | $2.0633 per EA | +0.04% |
IVERMECTIN 3 MG TABLET | $2.0633 per EA | +0.04% |
IVERMECTIN 0.5% LOTION | $1.2324 per GM | -1.42% |
SKLICE 0.5% LOTION | $0.2864 per GM | — |
Frequently Asked Questions
What is Ivermectin used to treat?
Ivermectin is used to treat ascariasis, elephantiasis, enterobiasis, mansonelliasis, onchocerciasis and scabies, per the National Library of Medicine's MED-RT classification.
When did Ivermectin become available as a generic?
FDA approved the first generic Ivermectin (ANDA) on Oct 24, 2014. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ivermectin?
In 2024, Medicare Part D spent $13 million on Ivermectin across 81,000 claims for 51,000 beneficiaries.
How many Ivermectin products are on the market?
The Ivermectin drug market contains 13 NDCs from 11 manufacturers — 8 generic and 5 brand products.
What is the price range for Ivermectin?
NADAC reference prices for Ivermectin range from $0.2864 to $15.5133 per GM — the most expensive product costs about 54× the cheapest. 5 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Ivermectin cheaper than brand?
The average generic NADAC for Ivermectin is $2.6205 per GM, versus $9.1497 for brand-labeled products — brand versions average about 3.5× the generic price.
Which manufacturers make Ivermectin?
11 manufacturers list Ivermectin in NADAC. Ranked by number of NDCs, the largest are Galderma Laboratories, L.P. (2), Merck Sharp & Dohme LLC (2), Viona Pharmaceuticals Inc. (1), Actavis Pharma, Inc. (1), Padagis Israel Pharmaceuticals Ltd (1).
How has the price of Ivermectin changed recently?
Over the past 7 days, 6 Ivermectin NDCs rose and 12 fell, with a market-wide average change of -1.3%.